Is a complete TELO research report available?

No complete published report is available for Telomir Pharmaceuticals, Inc. (TELO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Telomir Pharmaceuticals, Inc. (TELO)

NASDAQ: TELO · USD

$1.25

+0.04 (+3.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TELO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	86M
Net income (ttm)	-9.2M
EPS (ttm)	-$0.28
Shares out	68.8M
Volume	69,248
Beta	-0.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -9.2M
EPS (ttm): -$0.28
Market cap: 86M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TELO indicators

Market & fundamental data

Available fields

157

Groups with data

Currency

USD

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001971532
Company name	Telomir Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	87975F104
Enterprise value	$81M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-02-09
Isin	US87975F1049
Last refreshed	2026-07-31
Market cap	$86M
Market cap category	Micro-Cap
Price	$1.25
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	TELO
Website	https://telomirpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.73%
EV Sales Forward	53.97x
P/B ratio	8.66x
PS Forward	57.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-9.2M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
ROA	-186.9
ROCE	-189.3
ROE	-384.3
ROIC	-215.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-39.05%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$5.8M
Cash	$5.6M
Current Assets	$5.8M
Current Liabilities	$827,310
Debt	$547,695
Debt Equity	$0.11
Equity	$5M
Interest Coverage	-7,768.7
Liabilities	$827,310
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$5M
Net Cash By Market Cap	$5.83
Net Cash Growth	1,519.3%
Net Debt Equity	$-1.01
Tangible Book Value	$5M
Tangible Book Value Per Share	$0.14
WACC	2.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7
Net Working Capital	$-50,590
Quick ratio	6.72
Working Capital	$5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.22%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-39.02%
200-day SMA	1.32
50-day SMA	1.24
50-day SMA vs 200-day SMA	50under200
All Time High	20.72
All Time High Change	-93.97%
All Time High Date	2024-02-14
All Time Low	0.89
All Time Low Change	40.69%
All Time Low Date	2026-07-20
ATR	0.1
Beta	-0.24
Beta1y	1.46
Beta2y	1.59
Ch YTD	-6.02
High	1.25
High52	2.15
High52 Date	2025-07-30
High52ch	-41.86%
Low	1.25
Low52	0.89
Low52 Date	2026-07-20
Low52ch	40.69%
Ma50ch	1.13%
Price vs 200-day SMA	-5.09%
RSI	53.98
RSI Monthly	30.44
RSI Weekly	46.7
Sharpe ratio	-0.31x
Sortino ratio	-0.4
Total Return	-9.22%
Tr YTD	-6.02
Tr1w	7.76%
Tr3m	-13.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.07
Operating Income	$-9.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47,511,592%
Float Percent	69.08%
Net Borrowing	202,869
Shares Insiders	16.01%
Shares Institutions	3.3%
Shares Out	68,774,956
Shares Qo Q	2.65%
Shares Yo Y	9.22%
Short Float	2.05%
Short Ratio	8.01
Short Shares	1.42

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted OCF	-9,393,012
Average Volume	94,651.4x
Bv Per Share	0.14
Ch1w	7.76
Ch1y	-39.02
Ch3m	-13.79
Ch6m	2.46
Change	3.31%
Change From Open	0.4
Close	1.21
Days Gap	2.89
Dollar Volume	86,560
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-9.4M
EBITDA	$-9.4M
EPS	$-0.28
F Score	2
Financing CF	9,756,078
Fiscal Year End	December
Founded	2,021
Ipr	-82.14
Iprfo	-82.14
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-17
Ma150	1.28
Ma150ch	-2.27%
Ma20	1.19
Ma20ch	5.31%
Net CF	5,157,512
Next Earnings Date	2026-08-13
Open	1.25
Optionable	No
Position In Range	100
Post Close	1.25
Postmarket Change Percent	-4.8
Postmarket Price	$1.19
Price Date	2026-07-30
Ptbv Ratio	17.32
Relative Volume	0.73x
Share Based Comp	4,794,446
Tr6m	2.46%
Us State	Florida
Volume	69,248

Telomir Pharmaceuticals, Inc. (TELO)

Coverage state: Market snapshot only — no published research

Generate the first TELO analysis

Price

Financial snapshot

Fair-value bridge

Latest news · TELO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TELO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TELO

Frequently asked questions